Overview

Safety Study of Oxycodone Hydrochloride and Naltrexone Hydrochloride Extended-Release Capsules in Subjects With Moderate to Severe Chronic Noncancer Pain

Status:
Completed

Trial end date:
2012-05-01

Target enrollment:

Participant gender:

Summary

The study will provide information to assess the benefits versus risks of extended exposure to oxycodone HCl and naltrexone HCl extended-release capsules in a chronic noncancer pain population.

Phase:

Phase 3

Details

Lead Sponsor:

Pfizer

Treatments:

Naltrexone
Oxycodone